Use access key #2 to skip to page content.
$12.96 0.18 (1.41%)
9/5/2008 4:01 PM

Elan Corp, plc (ADR) (ELN)

CAPS Rating:
***

The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.

View All Commentary (ELN)

Recs

0

Avatar bermudatrader (90.29) Submitted: 1/26/08 4:18 PM : Outperform Start Price: $22.42 ELN Score: -35.56

Solid alzheimers pipeline and the best MS drug on the market.

Phase II results for AAb-001 come out this spring/summer, good data will propel this stock to the $40's.

Report this Post Replies: 0 | Reply

Featured Broker Partners